US5935975A - Agonist-antagonist combination to reduce the use of ...,http://www.google.com/patents/US5935975
US20160310599A1 - Compositions with high content of sesamin ...,https://www.google.com/patents/US20160310599
WO2014012632A1 - Microrna profiles in the diagnosis of multiple ...,https://google.com/patents/WO2014012632A1?cl=pt
"CA2514037C - Crystalline modification of 2-(3,5-bis-trifluoromethyl ...",https://www.google.com/patents/CA2514037C?cl=zh
CA2529493A1 - Administration of medicinal dry powders - Google ...,https://google.com/patents/CA2529493A1?cl=es
EP1378236A1 - Agents against stress-induced diseases drugs ...,https://www.google.com/patents/EP1378236A1?cl=ar
EP2714061A1 - Autism improving agent and autism improving tea ...,https://www.google.com/patents/EP2714061A1?cl=it
WO2010089616A1 - Optically active 3-[(phenylpiperazin-1-yl)alkyl ...,https://google.com/patents/WO2010089616A1?cl=it
CN104231013A - 一种天麻素阿魏酸酯类化合物及其制备方法与应用 ...,https://www.google.com/patents/CN104231013A?cl=ru
WO2010083968A1 - Compositions comprising a lipophilic extract of ...,https://www.google.com/patents/WO2010083968A1?cl=3Den
